Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

This study aimed to define the maximum-tolerated dose (MTD) of fixed dose rate (FDR) of gemcitabine (2′-2′-difluorodeoxycitidine) infusion with circulating haemopoietic progenitor support and to evaluate the activity of the treatment. Secondary end points were pharmacokinetic of gemcitabine and difl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bengala, C, Guarneri, V, Giovannetti, E, Lencioni, M, Fontana, E, Mey, V, Fontana, A, Boggi, U, Del Chiaro, M, Danesi, R, Ricci, S, Mosca, F, Del Tacca, M, Conte, P F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361486/
https://www.ncbi.nlm.nih.gov/pubmed/15986033
http://dx.doi.org/10.1038/sj.bjc.6602673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361486/
https://www.ncbi.nlm.nih.gov/pubmed/15986033
http://dx.doi.org/10.1038/sj.bjc.6602673

Ejemplares similares